Overview
Understanding AbbVie integration
Who this is for: Wholesalers, distributors, pharmacies, hospitals, and other customers that buy from AbbVie, and their purchasing, contract and finance teams.
Scope: This guide describes typical practice for this kind of trading relationship; AbbVie's own program details are confirmed during onboarding.
AbbVie, headquartered in North Chicago, Illinois, is a biopharmaceutical company with medicines in immunology, oncology, neuroscience and aesthetics, including the Allergan portfolio. ECOM's directory lists AbbVie under pharmaceutical manufacturing.
Aesthetics products are sold to physician practices through direct programs, while immunology and oncology medicines mostly move through wholesalers and specialty pharmacies. A pharmaceutical manufacturer typically sells through wholesalers and specialty distributors rather than directly to every pharmacy, so the main documents are orders and shipment notices from the wholesaler side, plus resale (867), inventory and chargeback (844) reporting. Direct accounts, such as hospitals or large chains, add invoices and remittance. DSCSA serialization data travels with product as a supply program requirement. The document set below is typical practice for this type of company; confirm the documents, X12 version, delivery method and testing steps with AbbVie for your own program.
ECOM helps confirm your trading program, map the required documents, configure connectivity, and complete testing against the applicable specifications. It then monitors every file after go-live and handles partner changes, as software, as a managed service or both.